Reaction Details |
| Report a problem with these data |
Target | Synaptic vesicle glycoprotein 2A |
---|
Ligand | BDBM50422542 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_100153 (CHEMBL857182) |
---|
IC50 | 794±n/a nM |
---|
Citation | Kenda, BM; Matagne, AC; Talaga, PE; Pasau, PM; Differding, E; Lallemand, BI; Frycia, AM; Moureau, FG; Klitgaard, HV; Gillard, MR; Fuks, B; Michel, P Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. J Med Chem47:530-49 (2004) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Synaptic vesicle glycoprotein 2A |
---|
Name: | Synaptic vesicle glycoprotein 2A |
Synonyms: | SV2A_RAT | Sv2 | Sv2a | Synaptic vesicle protein 2a |
Type: | PROTEIN |
Mol. Mass.: | 82648.76 |
Organism: | Rattus norvegicus |
Description: | ChEMBL_100153 |
Residue: | 742 |
Sequence: | MEEGFRDRAAFIRGAKDIAKEVKKHAAKKVVKGLDRVQDEYSRRSYSRFEEEEDDDDFPA
PADGYYRGEGAQDEEEGGASSDATEGHDEDDEIYEGEYQGIPRAESGGKGERMADGAPLA
GVRGGLSDGEGPPGGRGEAQRRKDREELAQQYETILRECGHGRFQWTLYFVLGLALMADG
VEVFVVGFVLPSAEKDMCLSDSNKGMLGLIVYLGMMVGAFLWGGLADRLGRRQCLLISLS
VNSVFAFFSSFVQGYGTFLFCRLLSGVGIGGSIPIVFSYFSEFLAQEKRGEHLSWLCMFW
MIGGVYAAAMAWAIIPHYGWSFQMGSAYQFHSWRVFVLVCAFPSVFAIGALTTQPESPRF
FLENGKHDEAWMVLKQVHDTNMRAKGHPERVFSVTHIKTIHQEDELIEIQSDTGTWYQRW
GVRALSLGGQVWGNFLSCFSPEYRRITLMMMGVWFTMSFSYYGLTVWFPDMIRHLQAVDY
AARTKVFPGERVEHVTFNFTLENQIHRGGQYFNDKFIGLRLKSVSFEDSLFEECYFEDVT
SSNTFFRNCTFINTVFYNTDLFEYKFVNSRLVNSTFLHNKEGCPLDVTGTGEGAYMVYFV
SFLGTLAVLPGNIVSALLMDKIGRLRMLAGSSVLSCVSCFFLSFGNSESAMIALLCLFGG
VSIASWNALDVLTVELYPSDKRTTAFGFLNALCKLAAVLGISIFTSFVGITKAAPILFAS
AALALGSSLALKLPETRGQVLQ
|
|
|
BDBM50422542 |
---|
n/a |
---|
Name | BDBM50422542 |
Synonyms: | Keppra | Keppra Xr | LEVETIRACETAM | Levetiracetam In Sodium Chloride | UCB-22059 | UCB-L059 |
Type | Small organic molecule |
Emp. Form. | C8H14N2O2 |
Mol. Mass. | 170.209 |
SMILES | CC[C@H](N1CCCC1=O)C(N)=O |r| |
Structure |
|